HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claire Gallois Selected Research

Tumor Biomarkers (Tumor Markers)

11/2022MSI colorectal cancer, all you need to know.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claire Gallois Research Topics

Disease

16Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 01/2021
8Colonic Neoplasms (Colon Cancer)
04/2024 - 10/2018
8Neoplasms (Cancer)
03/2024 - 10/2018
5Microsatellite Instability
03/2024 - 01/2022
4Neoplasm Metastasis (Metastasis)
10/2022 - 03/2021
2Disease Progression
10/2023 - 03/2020
2Gastric Outlet Obstruction
11/2022 - 04/2021
2Hemorrhage
06/2022 - 02/2017
2Adenocarcinoma
01/2021 - 03/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2023
1Ileitis
10/2023
1Colitis
10/2023
1Cholangiocarcinoma
10/2022
1Crohn Disease (Crohn's Disease)
06/2022
1Intestinal Perforation
06/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022
1Proteinuria
06/2022
1Ulcerative Colitis
06/2022
1Diarrhea
06/2022
1Hypertension (High Blood Pressure)
06/2022
1Peritoneal Neoplasms
01/2022
1Cardiotoxicity
01/2022
1Sarcopenia
11/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Stomach Neoplasms (Stomach Cancer)
03/2020
1Malnutrition (Nutritional Deficiencies)
01/2019

Drug/Important Bio-Agent (IBA)

8Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 10/2018
6Cetuximab (Erbitux)FDA Link
01/2023 - 10/2018
5Immune Checkpoint InhibitorsIBA
03/2024 - 10/2021
5encorafenibIBA
01/2023 - 01/2021
3Irinotecan (Camptosar)FDA LinkGeneric
10/2023 - 01/2021
2Sodium Glutamate (Accent)IBA
03/2024 - 01/2023
2Bevacizumab (Avastin)FDA Link
06/2022 - 10/2021
2pembrolizumabIBA
01/2022 - 10/2021
1GlucocorticoidsIBA
04/2024
1Prion ProteinsIBA
04/2024
1avelumabIBA
10/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Tumor Biomarkers (Tumor Markers)IBA
11/2022
1GemcitabineFDA Link
10/2022
1Infliximab (Remicade)FDA Link
06/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022
1regorafenibIBA
01/2022
1raltitrexed (D 1694)IBA
01/2022
1folfirinoxIBA
01/2022
1trifluridine tipiracil drug combinationIBA
01/2022
1Circulating Tumor DNAIBA
05/2021
1binimetinibIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1human ERBB2 proteinIBA
03/2020
1Trastuzumab (Herceptin)FDA Link
03/2020
1Monoclonal AntibodiesIBA
03/2020
1AnticoagulantsIBA
02/2017

Therapy/Procedure

12Drug Therapy (Chemotherapy)
03/2024 - 01/2019
5Adjuvant Chemotherapy
03/2024 - 10/2018
5Therapeutics
03/2024 - 02/2017
2Precision Medicine
04/2024 - 11/2022
1Immunotherapy
12/2023
1Gastroenterostomy
11/2022
1Stents
11/2022
1Contraindications
01/2022
1Gastric Bypass (Roux-en-Y Gastric Bypass)
04/2021
1Neoadjuvant Therapy
01/2021
1Operative Surgical Procedures
02/2017